Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtrer
1.
J Diabetes Complications ; 32(11): 1018-1024, 2018 Nov.
Article de Anglais | MEDLINE | ID: mdl-30236541

RÉSUMÉ

BACKGROUND: ACEs have a dose-response relationship with diabetes. The relationship between ACEs and pre-diabetes is not well known and may represent an effective area for prevention efforts. METHODS: Data from 1054 participants from two waves of the longitudinal MIDUS study were used. Multivariate general linear regression models assessed the relationship between ACEs and biomarker outcomes. Correlation tests and mediation models investigated the relationship between ACE and pre-diabetes. RESULTS: Individuals reporting ACEs were statistically significantly more likely to have higher BMI (1.13 (0.34-1.92)), higher waist circumference (2.74 (0.72-4.76)), elevated blood fasting insulin levels (2.36 (0.71-4.02)) and higher insulin resistance (HOMA-IR (0.57 (0.08-1.06)). BMI/waist circumference and insulin resistance did not maintain independent relationships with ACEs once HOMA-IR was included in the dichotomized ACE model (p = 0.05 and p = 0.06, respectively), suggesting the relationship between BMI and ACEs may be mediated by insulin resistance. CONCLUSIONS: These results represent one of the first studies to examine the differential impact of ACEs on a diverse set of clinical pre-diabetes measures. Findings suggest sexual and physical abuse, and financial strain during childhood are important factors associated with higher risk for pre-diabetes, and should be considered during intervention development.


Sujet(s)
Expériences défavorables de l'enfance/statistiques et données numériques , État prédiabétique/épidémiologie , Adulte , Sujet âgé , Indice de masse corporelle , Enfant , Études de cohortes , Femelle , Humains , Insulinorésistance , Études longitudinales , Mâle , Adulte d'âge moyen , États-Unis/épidémiologie
2.
Minerva Urol Nefrol ; 67(4): 325-33, 2015 Dec.
Article de Anglais | MEDLINE | ID: mdl-26329756

RÉSUMÉ

Percutaneous nephrolithotripsy (PCNL) is today gold standard for the management of complex urinary calculi. Over its lifespan this surgery has been subjected to multiple modifications and variants: for example, the anatomical positioning of the patient is still under controversy, especially the opposition amongst the prone and supine approaches, the two most common patient positions currently used for PCNL. Our objective was to review the literature and to discuss advantages and drawbacks from either technique.


Sujet(s)
Néphrostomie percutanée/méthodes , Décubitus ventral , Décubitus dorsal , Calculs urinaires/thérapie , Humains , Calculs rénaux , Néphrostomie percutanée/effets indésirables , Résultat thérapeutique
3.
Dermatol Online J ; 15(5): 12, 2009 May 15.
Article de Espagnol | MEDLINE | ID: mdl-19624990

RÉSUMÉ

A 48-year-old woman was hospitalized with the diagnosis of hepatitis. She presented with symptoms of jaundice, headache, elevated bilirubin, and elevated hepatic enzymes. She related a recent episode of a bronchial infection that was treated during the previous eight days with paracetamol (500mg, 2 doses only), chlorpheniramine, betamethasone and clindamycin. After an initial clinical and laboratorial improvement, she began to complain of pruritus of the palms and soles. Thereafter, vesicles evolving to blisters developed and a deterioration of her general health ensued. Serologies for hepatitis A, B, and C viruses were negative. Intrahepatic cholestasis and Stevens Johnson Syndrome (SJS) were the final diagnosis. The association of the Stevens Johnson Syndrome and intrahepatic cholestasis simultaneously, related to adverse drug reactions, is very rare. The drugs reportedly involved are mainly antibiotics, such as ampicillin, vancomycin, amoxicillin/clavulinic acid and erythromycin. Other drugs involved are non-steroidal anti-inflamatory drugs, such as mefenamic acid, ibuprofen, and sulindac. The reactions can be minor or severe and can even cause death, an outcome that has been reported in patients of all races and ethnic groups, but appears to be more rare in patients of Latin origin. We present a discussion of this case and review the main characteristics of the Stevens Johnson Syndrome.


Sujet(s)
Chlorphénamine/effets indésirables , Cholestase intrahépatique/induit chimiquement , Clindamycine/effets indésirables , Syndrome de Stevens-Johnson/étiologie , Acétaminophène/administration et posologie , Acétaminophène/usage thérapeutique , Bétaméthasone/administration et posologie , Bétaméthasone/usage thérapeutique , Bronchite/complications , Bronchite/traitement médicamenteux , Chlorphénamine/administration et posologie , Chlorphénamine/usage thérapeutique , Cholestase intrahépatique/traitement médicamenteux , Clindamycine/administration et posologie , Clindamycine/usage thérapeutique , Diabète de type 2/complications , Diabète de type 2/traitement médicamenteux , Association de médicaments , Énalapril/usage thérapeutique , Femelle , Dermatoses du pied/étiologie , Dermatoses de la main/étiologie , Humains , Insuline/usage thérapeutique , Méthylprednisolone/usage thérapeutique , Adulte d'âge moyen , Inflammation muqueuse/étiologie , Syndrome de Stevens-Johnson/traitement médicamenteux
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE